SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-14-369147
Filing Date
2014-10-10
Accepted
2014-10-10 16:15:37
Documents
1
Group Members
VEF MANAGEMENT III, LLCVENROCK ASSOCIATESVENROCK ENTREPRENEURS FUND III, L.P.VENROCK MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d803537dsc13d.htm SC 13D 114624
  Complete submission text file 0001193125-14-369147.txt   116292
Mailing Address
Business Address 30 ROCKEFELLER PLAZA RM 5508 NEW YORK NY 10112
VENROCK ASSOCIATES III LP (Filed by) CIK: 0001119517 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Subject) CIK: 0001157602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88337 | Film No.: 141152582
SIC: 2834 Pharmaceutical Preparations